Mangrove Therapeutics Inc. research brief

CIK 2111089 Copy CIK

Generated Nov. 4, 2026, 10:57 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SACRAMENTO CA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• July 31, 2026 · D · 0002111089-26-000001 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 2455000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Mangrove Therapeutics Inc. research brief,” CIK 2111089, retrieved Nov. 4, 2026, 10:57 p.m.. Cite the specific accessions used. No amounts have been summed.